Effects of berberine on LPS /NF-κB and MAPK signaling pathways in PCOS model rats

doi:10.12047/j.cjap.6229.2022.029

Abstract

Abstract: Objective: To investigate the effects of berberine on glucose and lipid metabolism, sex hormone binding protein, adiponectin (LPS), NF-κB and MAPK signaling pathways in polycystic ovary syndrome (PCOS) model rats. Methods: Female SD rats were randomly divided into control group, PCOS model group, berberine (0.216 g/kg) group, metformin (0.135 g/kg) group and Dyne-35 (0.18 mg/kg) group, 10 rats in each group. The rats in PCOS model group were treated with letrozole 1 mg.kg^-1 by ig for 3 weeks. After 28 days of drug intervention, the body constitution, ovarian and uterine indexes of the rats were detected, and the changes in the number of ovarian follicles were observed by HE staining. The levels of serum sex hormone, glucose and insulin, triglyceride and cholesterol, sex hormone-binding protein and adiponectin were determined by ELISA, and the protein expressions of p38-MAPK, C-Jun and NF-κB in ovarian tissues were determined by Western blot. Results: Compared with control group, body weight of model group was increased (P＜0.05), and uterine index was decreased (P＜0.05); The number of follicles was increased (P＜0.05). Serum levels of luteinizing hormone (LH), testosterone (T) and LH/FSH ratio were increased (P＜0.05), follicular estrogen (FSH) level was decreased (P＜0.05), total cholesterol (TC), triglyceride (TG), fasting insulin and insulin index (HOMA) were increased (P＜ 0.05). The content of sex hormone binding protein (SHBG) was decreased and the content of adiponectin (LPS) was increased (P＜0.05). The protein expressions of p38-MAPK, c-Jun and NF-κB in ovarian tissue were up-regulated (P＜0.05). Compared with model group, in berberine group, the uterine index and the number of secondary follicles were increased(P＜0.05), the serum levels of luteinizing hormone (LH) , testosterone (T) and the ratio of LH/FSH were decreased (P＜0.05), and the protein expression levels of p38-MAPK and NF-κB in ovarian tissue were down-regulated (P＜0.05), which were similar to those of Dyne-35 group. Berberine significantly decreased serum triglyceride (TG), insulin level and insulin index (P＜0.05), increased serum SHBG level and decreased serum LPS level (P＜0.05), which were similar to those of metformin. Conclusion: Berberine can regulate sex hormone disorder and insulin resistance (IR) in PCOS rats by down-regulating the expressions of p38-MAPK and NF-κB protein in ovarian tissues and decreasing the serum content of LPS.

Key words: polycystic ovary syndrome (PCOS), adiponectin (LPS), berberine, p38-MAPK, NF-κB, c-Jun protein, Rat

CLC Number:

R711.5

ZHAO Fen-qin, ZHAO Yan, LIU Jie-ying, GOU Ya-jiao, YANG Yong-qin. Effects of berberine on LPS /NF-κB and MAPK signaling pathways in PCOS model rats[J]. CJAP, 2022, 38(2): 181-186.

References

[1] Glueck CJ, Goldenberg N. Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics[J]. Metabolism, 2019, 92: 108-120.
[2] 宋颖, 李蓉. 多囊卵巢综合征中国诊疗指南解读[J]. 实用妇产科杂志, 2018, 34(10): 737-741.
[3] Patel S.Polycystic ovary syndrome(PCOS),an inflammatory, systemic, lifestyle endocrinopathy[J]. J Steroid Biochem Mol Biol, 2018, 182: 27-36.
[4] Cooney LG, Dokras A.Cardiometabolic risk in polycystic ovary syndrome:Current guidelines[J]. Endocrinol Metab Clin North Am, 2021, 50(1): 83-95.
[5] 郭锐, 秦卫帅, 张双勇, 等. 加味逍遥散对LPS诱导的抑郁模型大鼠海马小胶质细胞TLR4/NF-κB通路的影响[J]. 中国应用生理学杂志, 2020, 36(4): 354-357.
[6] Zhou DN, Li SJ, Ding JL, et al. MIF May participate in pathogenesis of polycystic ovary syndrome in rats through MAPK signalling pathway[J]. Curr Med Sci, 2018, 38(5): 853-860.
[7] 孙淼, 祝鑫瑜, 孟小钰, 等. 基于LPS/TLR4/NF-κB信号通路探讨中药治疗多囊卵巢综合征慢性低度炎症研究进展[J]. 中华中医药学刊, 2021, 39(8): 128-132.
[8] 李萍, 梁琳琅, 王宇, 等. 二甲双胍和西格列汀对胰岛素抵抗糖尿病前期KKAy小鼠胰岛β细胞功能的影响[J]. 中国应用生理学杂志, 2021, 37(6): 644-650.
[9] Glintborg D.Endocrine and metabolic characteristics in polycystic ovary syndrome[J]. Dan Med J, 2016, 63(4): 5232-5260.
[10] 李春林, 张翥, 曾荣荣, 等. 黄连水提物对LPS诱导的猪肠道上皮细胞IL-1β、IL-6、TNF-α mRNA表达及NF-κB/MAPK信号通路的调控作用[J]. 中国兽医学报, 2020, 40(2): 361-368.
[11] 何淑霞, 俞峭拔, 何淑敏, 等. 黄连素对伴胰岛素抵抗的多囊卵巢综合征大鼠卵巢状态的影响[J]. 中国临床药理学杂志, 2020, 36(14): 2045-2048.
[12] Li W, Li D, Kuang H, et al. Berberine increases glucose uptake and intracellular ROS levels by promoting Sirtuin 3 ubiquitination[J]. Biomed Pharmacother, 2020, 121: 109563(1-10).
[13] 范春芳, 郭一沙, 王嘉欢, 等. 黄连素对糖尿病大鼠胰岛素抵抗的治疗作用[J]. 中国应用生理学杂志, 2020, 36(6): 561-564.
[14] 赵颖, 杨园园, 杜雅薇, 等. 黄连素治疗血脂异常有效性和安全性随机对照临床试验的系统评价与Meta分析[J]. 中国中药杂志, 2020, 45(3): 664-673.
[15] 李菲, 张宁, 周冠伦. 肠道菌群与多囊卵巢综合征的免疫学机制研究进展[J]. 现代妇产科进展, 2018, 27(4): 308-310.
[16] 张瑜, 路青华, 曹海芳, 等. GPR81激动剂对非酒精性脂肪肝病大鼠胰岛素抵抗的影响[J]. 中国应用生理学杂志, 2021, 37(4): 354-358.
[17] Kobayashi M, Yoshino O, Nakashima A, et al. Inhibition of autophagy in theca cells induces CYP17A1 and PAI-1 expression via ROS/p38 and JNK signalling during the development of polycystic ovary syndrome[J]. Mol Cell Endocrinol, 2020, 508: 110792.
[18] Wei W, Zhao H, Wang A, et al. A clinical study on the short term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycysticovary syndrome[J]. Eur J Endocrinol, 2012, 66(1): 99-105.
[19] Xie L, Zhang D, Ma H, et al. The effect of berberine on reproduction and metabolism in women with polycystic ovary syndrome:A systematic review and meta-analysis of randomized control trials[J]. Evid Based Compl Alt Med, 2019, 2019: 1-14.
[20] 常惠, 吴效科. 黄连素对PCOS治疗作用及相关机制研究进展[J]. 现代妇产科进展, 2017, 26(3): 235-237.
[21] Akintayo CO, Johnson AD, Badejogbin OC, et al. High fructose-enriched diet synergistically exacerbates endocrine but not metabolic changes in letrozole-induced polycystic ovarian syndrome in Wistar rats[J]. Heliyon, 2021, 7(1): 5890-5897.